SpectrumAi is modernizing and democratizing access to high-quality autism treatment.
SpectrumAi has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
SpectrumAi's investors include CVS Health, Frist Cressey Ventures, F-Prime Capital, Autism Impact Fund, Difference Partners.
SpectrumAi is headquartered in Los Angeles, United States.
SpectrumAi is modernizing and democratizing access to high-quality autism treatment.
SpectrumAi is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SpectrumAi — Funding & Investors." VCBacked, March 16, 2023, https://www.vcbacked.co/company/spectrumai. Accessed September 15, 2026.
VCBacked. (2023). SpectrumAi — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/spectrumai
{{cite web |title=SpectrumAi — Funding & Investors |url=https://www.vcbacked.co/company/spectrumai |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated